InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-3.8%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Trowbridge Stephen A, Chief Financial Officer. Director active across 1 company, notably Angiodynamics INC. Aggregated, 28 reports have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €53k. History available since 14 July 2021. The latest transaction was filed on 13 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations28 total
890 shares@ US$11.161.8% of flowCommon StockSEC:0001140361-25-038018:0
Canonical exit: 11 Jan 2026 (T+90)
2,585 shares@ US$8.694.1% of flowCommon StockSEC:0001140361-25-026800:0
717 shares@ US$8.691.1% of flowCommon StockSEC:0001140361-25-026800:1
667 shares@ US$8.991.1% of flowCommon StockSEC:0001140361-25-026800:2
86,997 shares0Common StockSEC:0001140361-25-026462:0
1,700 shares@ US$5.861.9% of flowCommon StockSEC:0001140361-24-043173:0
Canonical exit: 6 Jan 2025 (T+90)
11,142 shares0Common StockSEC:0001140361-24-035597:0
717 shares@ US$7.131.0% of flowCommon StockSEC:0001140361-24-034268:0
38,953 shares0Common StockSEC:0001140361-24-033629:0
1,927 shares@ US$4.671.7% of flowCommon StockSEC:0001140361-24-011190:0
19,354 shares0Common StockSEC:0001140361-23-044840:0
8,769 shares0Common StockSEC:0001140361-23-036318:0
717 shares@ US$8.741.2% of flowCommon StockSEC:0001140361-23-036121:0
667 shares@ US$8.651.1% of flowCommon StockSEC:0001140361-23-036121:1
28,691 shares0Common StockSEC:0001140361-23-035726:0
1,362 shares@ US$9.632.4% of flowCommon StockSEC:0001140361-23-035087:0
376 shares@ US$9.560.7% of flowCommon StockSEC:0001140361-23-035087:1
555 shares@ US$13.431.4% of flowCommon StockSEC:0001567619-23-002005:0
1,083 shares@ US$13.823.2% of flowCommon StockSEC:0001567619-22-018449:0
Canonical exit: 10 Jan 2023 (T+90)
7,961 shares0Common StockSEC:0001567619-22-014367:0
14,758 shares@ US$15.9549.2% of flowCommon StockSEC:0001567619-22-014114:0
4,188 shares0Common StockSEC:0001567619-22-013844:0
583 shares@ US$20.480.0024% mcap7.9% of flowCommon StockSEC:0001567619-22-002518:0
1,000 shares@ US$22.640.0045% mcap14.9% of flowCommon StockSEC:0001567619-22-001116:0
Canonical exit: 12 Apr 2022 (T+90)
10,946 shares0Common StockSEC:0001567619-21-016021:0
25 of 28 declarations
About Trowbridge Stephen A
Stephen A. Trowbridge is the Executive Vice President and Chief Financial Officer of AngioDynamics Inc. He oversees the financial management of the company, including budget planning and financial reporting. His role is essential in ensuring AngioDynamics's financial health.
